Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5699453 | Clinical Oncology | 2009 | 9 Pages |
Abstract
There was general support for dose-banding, but concerns about the lack of an evidence base could be a barrier to the wider introduction of the system. Consequently, more clinical studies are required to justify the safety and efficacy of dose-banding, and also to evaluate whether dose-banding is acceptable within clinical trials.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S.A. Kaestner, G.J. Sewell,